NEW YORK, NY, Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., has raised $50 million in Series B financing.
The funding round is led by Transformational Capital, with participation from Edison Partners, who led Capital Rx's Series A financing in 2019.
Capital Rx is a health technology company that is leading the transformation of the pharmacy benefits industry. Capital Rx's enterprise pharmacy platform, JUDI™, digitally links providers, patients, pharmacies, and plans to achieve the highest standard of clinical care. By establishing a competitive marketplace through its Clearinghouse Model™, Capital Rx unlocks the pharmacy supply chain to ensure patients receive seamless access to medication at the lowest price.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
